• ExplainersExplainers
    Regulatory NewsRegulatory News

    Regulatory Explainer: Everything You Need to Know About Biosimilars

    For more than a decade now, biotech and pharmaceutical companies have brought a new class of treatments – biosimilars – to markets around the world (from the EU to India to South Korea to the US), offering cost savings for some of the most expensive medicines, though even in 2016, decades after companies began their quest to develop biosimilars, they are still only just beginning to see widespread adoption. What is a Biosimilar? A biosimilar medicine (also sometimes k...
  • Regulatory NewsRegulatory News

    IMS: Biosimilars Could Save Up to $110B in EU, US Through 2020

    With 56 new biosimilars in clinical development, IMS Consulting Group says in a new report that the biologic competitors could save health systems across Europe and the US as much as $110 billion through 2020. But the savings for both regions will vary considerably as payers have adopted a variety of approaches to encourage physicians to prescribe biosimilars, motivate manufacturers and require certain clinical evidence to support the prescribing of these treatments. Fo...
  • GPhA: 505(j) Provisions Saved US $1 Trillion Since 2002

    Abbreviated new drug applications-also known as generic drug applications or 505(j) applications-have saved US citizens more than a trillion dollars in the past decade, says a new report out from the health data analytics firm IMS Health and sponsored by the Generic Pharmaceutical Association (GPhA). The report, " Savings: $1 Trillion Over 10 Years ," comes as healthcare costs continue to rise, outpacing inflation on a consistent basis. Generic medicines, says the repo...
  • 'Job-Killing' Safety Regulations Not So Job-Killing, Claims Study

    • 18 May 2012
    A new study published in the journal Science looking at safety regulations at worksites in California shows companies making an effort to strengthen safety measures for their employees cut down on workers' compensation costs while maintaining their levels of profit. "These inspections ironically appear to be creating value for the firms that they are visiting in terms of reduced workers compensation costs and frequency of injuries," said study co-author and Harvard Pro...